< back to search

Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5.

Huang, Feng   •   Sun, Fei   •   Wan, Wei-Guo   •   Wu, Li-jun   •   Dong, Ling-Li   •   Zhang, Xiao   •   Kim, Tae-Hwan   •   Sengupta, Raj   •   Šenolt, Ladislav   •   Wang, Yi   •   Qiu, Hao-Min   •   Porter, Brian   •   Haemmerle, Sibylle

published in: Chinese medical journal



▼
▲